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Simian immunodeficiency virus of chimpanzees (SIVcpz) has a significant negative impact on the health,
reproduction, and life span of chimpanzees, yet the prevalence and distribution of this virus in wild-living
populations are still only poorly understood. Here, we show that savanna chimpanzees, who live in ecologically
marginal habitats at 10- to 50-fold lower population densities than forest chimpanzees, can be infected with
SIVcpz at high prevalence rates. Fecal samples were collected from nonhabituated eastern chimpanzees (Pan
troglodytes schweinfurthii) in the Issa Valley (n  375) and Shangwa River (n  6) areas of the Masito-Ugalla
region in western Tanzania, genotyped to determine the number of sampled individuals, and tested for
SIVcpz-specific antibodies and nucleic acids. None of 5 Shangwa River apes tested positive for SIVcpz; however,
21 of 67 Issa Valley chimpanzees were SIVcpz infected, indicating a prevalence rate of 31% (95% confidence
interval, 21% to 44%). Two individuals became infected during the 14-month observation period, documenting
continuing virus spread in this community. To characterize the newly identified SIVcpz strains, partial and
full-length viral sequences were amplified from fecal RNA of 10 infected chimpanzees. Phylogenetic analyses
showed that the Ugalla viruses formed a monophyletic lineage most closely related to viruses endemic in
Gombe National Park, also located in Tanzania, indicating a connection between these now separated com-
munities at some time in the past. These findings document that SIVcpz is more widespread in Tanzania than
previously thought and that even very low-density chimpanzee populations can be infected with SIVcpz at high
prevalence rates. Determining whether savanna chimpanzees, who face much more extreme environmental
conditions than forest chimpanzees, are more susceptible to SIVcpz-associated morbidity and mortality will
have important scientific and conservation implications.
Among the many lentiviruses known to infect Old World
primates in sub-Saharan Africa, simian immunodeficiency vi-
rus of chimpanzees (SIVcpz) is of particular interest because it
is the immediate precursor of human immunodeficiency virus
type 1 (HIV-1), the causative agent of AIDS (8, 16). However,
SIVcpz is also an important pathogen in its own right, since it
causes significant morbidity and mortality in its chimpanzee
host (6, 15, 37). Recent natural history studies in Gombe Na-
tional Park in western Tanzania showed that infected chim-
panzees have a 10- to 16-fold increased risk of death compared
to uninfected chimpanzees (15). SIVcpz-infected females were
less likely to give birth and their infants had a much higher
mortality rate than those of uninfected females (15). Most
importantly, postmortem analyses showed that SIVcpz can
cause CD4 T lymphocyte depletion and histopathological
findings consistent with end-stage AIDS (15). These results
demonstrated that SIVcpz has a substantial negative impact on
the health, reproduction, and life span of chimpanzees, a con-
clusion that was further substantiated by the identification of
an SIVcpz-infected orphan chimpanzee in Cameroon, who suf-
fered from progressive CD4 T cell loss, severe thrombocyto-
penia, and clinical AIDS (6). Thus, current data indicate that
SIVcpz infection may pose a significant threat to infected com-
munities in the wild.
Chimpanzees (Pan troglodytes) are widely dispersed across
sub-Saharan Africa and classified into four subspecies with
nonoverlapping ranges (7, 9, 11). These include the western
subspecies Pan troglodytes verus, the Nigeria-Cameroonian sub-
species P. t. ellioti, the central subspecies P. t. troglodytes, and
the eastern subspecies P. t. schweinfurthii. Thus far, SIVcpz
infection has been documented only in members of the P. t.
troglodytes and P. t. schweinfurthii subspecies (44). This is most
likely because chimpanzees acquired SIV by cross-species
transmission from monkeys on which they prey after the split
of P. t. verus and P. t. ellioti from the other two subspecies.
Indeed, phylogenetic analyses have shown that SIVcpz repre-
sents a complex mosaic, generated by recombination of two
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lineages of SIV infecting red-capped mangabeys and Cerco-
pithecus monkey species (3). Since the current habitat of these
species overlaps that of central chimpanzees, it is likely that
SIVcpz first emerged in west central Africa and then spread
eastward, either during or subsequent to the divergence of
central and eastern chimpanzees.
Chimpanzees are highly endangered and reclusive, which
precludes invasive testing of any kind (27). To screen wild-
living populations for SIVcpz infection, our laboratory has
developed diagnostic methods that detect virus-specific anti-
bodies and nucleic acids in fecal and urine samples with high
sensitivity and specificity (16, 41, 42). These noninvasive meth-
ods, combined with genotyping approaches for species confir-
mation and individual identification (5, 15, 37, 47, 50), have
enabled analyses of wild-living chimpanzee populations
throughout central Africa. Molecular epidemiological studies
have shown that SIVcpz is endemic in both central and eastern
chimpanzees, with virus-positive communities identified
throughout their habitats (43, 44). Surprisingly, however, the
distribution of SIVcpz in wild-living populations is uneven,
with high prevalence rates (30% to 50%) in some communities
and rare or absent infection in others (15, 16, 19, 37, 41, 49).
While the reasons for this sporadic distribution remain to be
determined, it is clear that the infection status of any one
community cannot be predicted but has to be determined em-
pirically.
The first wild chimpanzee with SIVcpz infection was identi-
fied in Gombe in 2000 (42). Since then, the resident Mitumba,
Kasekela, and Kalande communities have been screened ex-
tensively, with most members tested biannually. These studies
have revealed widespread SIVcpz infection, with prevalence
rates of 13%, 12%, and 46% for the Mitumba, Kasekela, and
Kalande communities, respectively (37). Behavioral and viro-
logical studies also showed that SIVcpz spreads primarily by
sexual routes, with a probability of transmission per coital act
of about 0.001, very similar to that for HIV-1-infected hetero-
sexual humans (10, 37). The major route of virus spread be-
tween communities was found to occur via migration of in-
fected females (37). Finally, demographic studies identified an
association between SIVcpz prevalence and population size.
The Kalande community, which consistently had the highest
SIVcpz prevalence, suffered a catastrophic population decline,
while the sizes of the Mitumba and Kasekela communities,
which were infected at much lower levels, remained stable
(37).
The finding of SIVcpz in Gombe prompted surveys of chim-
panzee communities in other areas of East Africa (Fig. 1A).
These included the Kanyawara and Ngogo communities in
Kibale National Park in western Uganda, habituated chimpan-
zees in the Budongo Forest in northern Uganda, and members
of the M group in Mahale Mountains National Park in western
Tanzania (44). In addition, surveys were conducted in the
Kyambura Gorge and the Bwindi Impenetrable Forest in
southern Uganda and the Nyungwe Forest Reserve in western
Rwanda (unpublished data). Although over 500 fecal and
urine samples were screened, none of these was positive for
SIVcpz antibodies and/or nucleic acids. In contrast, SIVcpz
was detected at multiple field sites throughout the Democratic
Republic of the Congo (19, 43). These data suggested that
chimpanzees at the easternmost limits of the P. t. schweinfurthii
range were largely free of SIVcpz infection, possibly because of
severely fragmented habitats and/or other biogeographical bar-
riers that impeded virus spread and/or had caused its extinc-
tion. The presence of SIVcpz in Gombe thus seemed to rep-
resent an isolated occurrence, perhaps a remnant from a past
dispersal, with no demonstrable linkages to other communities.
To examine whether the Gombe chimpanzees were indeed
an exception, we surveyed apes in additional areas of Tanzania.
Western Tanzania is home to an estimated 2,700 to 2,800
wild-living chimpanzees (26, 32), only about 25% of whom live
in the protected areas of Gombe and Mahale Mountains (Fig.
1B). An estimated 2,600 live in the Greater Mahale Ecosystem,
which includes Mahale Mountains National Park and the re-
gions of Masito and Ugalla. The latter areas encompass some
of the most arid habitats in which chimpanzees have been
found (Fig. 1C). Apes living in Masito and Ugalla have
adapted to exceptional living conditions (Fig. 1D). Such “sa-
vanna chimpanzees” occupy much larger home ranges, live at
10- to 50-fold lower population densities, and face more ex-
treme seasonal changes than forest chimpanzees (4, 23–25).
Because of their challenging environment, savanna chimpan-
zees are also predicted to differ in aspects of their behavior and
social structure from forest chimpanzees (24, 25). Finally, they
are often used as a model system for the behavioral ecology of
early hominids, who are believed to have evolved in similar
habitats (24, 34). Here, we report the first survey of savanna
chimpanzees for SIVcpz infection.
MATERIALS AND METHODS
Study site. The Ugalla study area lies in the northeastern portion of the
Greater Mahale Ecosystem, about 80 km inland from Lake Tanganyika, and
includes the study sites of the Issa Valley and Shangwa River (Fig. 1B). Ugalla
itself is a 3,300-km2 region of broad valleys broken up by steep mountains and
flat hilltop plateaus 900 to 1,800 m in elevation. The boundaries of this area are
(i) the Uvinza-Mpanda Road to the west, (ii) the Malagarasi River to the north,
(iii) the Ugalla River to the east, and (iv) a decline in elevation to the south (Fig.
1B). Miombo woodland, named for the dominant tree genera of Brachystegia and
Julbernardia, dominates the landscape, interspersed with grassland, riverine for-
est strips, and small patches of swamp. Only 1.7% of the region is evergreen
forest, located principally in the thin riverine strips (Fig. 1C). There is a rainy
season (October to April) and a dry season (May to September), with dry months
defined as having less than 100 mm of rainfall. Rainfall averages less than 1,000
mm per annum (13), and temperatures range from 11 to 35°C.
Sample collection. Chimpanzees in the Ugalla area are not habituated. In the
Issa Valley, they were tracked using an acoustic system that monitored nighttime
vocalizations to identify the location of nesting sites (30). At the Shangwa River
site, they were tracked by an experienced field assistant familiar with the area.
Most fecal samples were collected early in the morning, after the chimpanzees
had left their night nests. Samples were also collected during biweekly walked
line transects or when encountered opportunistically. Fecal samples (10 to
20 g) were placed into 50-ml conical tubes and mixed with an equal volume of
RNAlater (Ambion). Tubes were labeled with a sample code and the Global
Positioning System (GPS) coordinates of the collection site. Samples were stored
at ambient temperature until transported to the Jane Goodall Institute in
Kigoma, Tanzania, where they were stored at 20°C. Samples were shipped to
the University of Alabama at Birmingham at ambient temperature and stored at
80°C thereafter.
SIVcpz antibody detection. All fecal samples were screened for the presence of
SIVcpz-specific antibodies using an enhanced chemiluminescence Western blot
approach as previously reported (15, 16, 41). Sample integrity was confirmed
using an IgG control.
Viral RNA extraction and amplification. Fecal RNA was extracted from
SIVcpz antibody-positive samples using an RNAqueous Midi Kit (Ambion) and
subjected to reverse transcription-PCR (RT-PCR) amplification using SIVcpz-
specific pol, gp41, and gp41/nef consensus primers as previously described (15, 16,
37, 41, 42). All amplicons were gel purified and sequenced directly.
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Individual identification. All samples were subjected to mitochondrial DNA
(mtDNA) and microsatellite analyses to confirm their species origin and deter-
mine the number of sampled individuals. Fecal DNA was extracted as described
previously (15, 16, 37, 41, 42). A 419-bp fragment of the mitochondrial D-loop
region was amplified, sequenced, and subjected to phylogenetic analysis (39) to
identify distinct mitochondrial haplotypes (see Fig. S1 in the supplemental ma-
terial). All samples were genotyped at eight autosomal microsatellite loci (5, 15,
16, 37, 50), with amplification products analyzed on an automated sequencer
(Applied Biosystems) and sized using the GeneMapper, version 4.0, program
(Applied Biosystems). For individual identification, samples were first grouped
by mitochondrial DNA haplotypes. Within each haplotype, samples were then
grouped by microsatellite genotypes at eight loci (see Table S1 in the supple-
mental material). Due to the prolonged storage at ambient temperatures, we
suspected partial sample degradation. To guard for potential allelic dropout, we
thus allowed allelic mismatches at up to four loci, but only if they represented a
missing allele. This genotyping approach is rather conservative and may have
resulted in an underestimation of the number of individuals screened. Gender
was determined by amplifying a region of the amelogenin gene that contains a
6-bp insertion in the Y chromosome but not the X chromosome. Samples with
evidence of DNA admixture (multiple peaks for the same locus or double peaks
in the mtDNA sequence) were discarded.
SIVcpz prevalence determination. The prevalence of SIVcpz infection was
estimated on the basis of the proportion of infected individuals determined by
microsatellite analyses. For each chimpanzee, the probability that it would be
detected as being infected, if it was truly infected, was calculated by taking into
consideration the number of specimens analyzed as well as the sensitivity of the
fecal antibody detection test, previously estimated to be 0.92 (16). SIVcpz prev-
alence was then estimated as the proportion of chimpanzees identified to be
infected, but corrected for this sensitivity; 95% confidence limits were calculated
on the basis of binomial sampling.
Full-length genome amplification. Full-length SIVcpz sequences were gener-
ated by amplifying partially overlapping subgenomic fragments from fecal RNA
as described previously (40, 47, 48). Amplicons were gel purified and sequenced
directly. Chromatograms were examined for positions of base mixtures using the
Sequencher (version 4.7) program (Gene Codes Corporation, Ann Arbor, MI).
Nucleotide differences between adjoining fragments in regions of sequence over-
lap were recorded. Ambiguous sites were resolved as previously reported (48).
Briefly, for positions that did not affect the corresponding amino acid, the
predominant nucleotide (the one with the highest amplitude in the sequence
chromatogram or the most frequent nucleotide in repeat sequencing reactions)
was chosen. For positions that affected the corresponding amino acid, the base
that encoded the more common amino acid residue in alignments of existing
SIVcpz and HIV-1 protein sequences was selected. In the absence of an apparent
common amino acid (e.g., in hypervariable protein regions), the nucleotide with
the highest amplitude in the sequence chromatograms was selected. Using these
criteria, all ambiguous sites were resolved, except for two positions in the long
terminal repeat (LTR) region of UG31.
Distance plots. Distance plots comparing the newly derived SIVcpzUG38,
SIVcpzUG31, and SIVcpzTAN5 sequences to each other and to the SIVcpzANT
reference strain were generated using SimPlot (version 3.5.1) software (21).
Pairwise distance values were calculated for a window of 300 bp moved in
20-base increments along the alignment. Regions that could not be unambigu-
ously aligned were removed from the analysis.
Phylogenetic analyses. Partial pol (HXB2 coordinates 4107 to 4775) and gp41/
nef (8358 to 9054) sequences from the newly characterized Ugalla viruses were
FIG. 1. The Ugalla study site. (A) Location of Ugalla (UG) in
western Tanzania (star) relative to other chimpanzee study sites (cir-
cles) in east Africa (BG, Budongo Forest; NY, Nyungwe Forest Re-
serve; KB, Kibale National Park; KG, Kyambura Gorge; BW, Bwindi
Impenetrable Forest; GM, Gombe National Park; MH, Mahale Moun-
tains National Park); sites where SIVcpz was found are highlighted in
red. An inset depicts the location of this region within Africa.
(B) Shaded reliefmap of northwestern Tanzania. The locations of the
85-km2 fecal collection area in the Issa Valley (yellow oval) and a
single site near the Shangwa River site (yellow circle) within the
greater Ugalla region (magenta) are shown in relation to the locations
of Gombe and Mahale Mountains National Parks. The Mishamo Ref-
ugee Settlement is indicated by hatch marks. Green areas denote
evergreen forested regions, while brown areas indicate open and dense
Miombo woodlands derived from 2007 satellite imagery (unpublished
data). Orange shaded areas indicate potential savanna chimpanzee
nesting habitat predicted as described previously (26). (C) Typical
Miombo woodlands in the Ugalla region during the dry season. (D)
Picture of a savanna chimpanzee taken by a motion-triggered camera
(photo credit: Ugalla Primate Project and the Max Plank Institute for
Evolutionary Anthropology).
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aligned to P. t. schweinfurthii SIVcpz (SIVcpzPts) reference sequences from
Gombe and the Democratic Republic of the Congo by using the CLUSTAL W
program (18). GenBank accession numbers are as indicated for the following
SIVcpzPts strains: ANT, U42720; TAN1, AF447763; TAN2, DQ374657; TAN3,
DQ374658; TAN5, FJ895394 and FJ895382; TAN6, FJ895395 and FJ895383;
TAN8, FJ895403 and FJ895389; TAN9, FJ895405; TAN10, FJ895398 and
FJ895386; TAN11, FJ895399 and FJ895387; TAN12, FJ895400 and FJ895388;
TAN13, FJ895393 and FJ895381; TAN14, FJ895397 and FJ895385; TAN15,
FJ895404; TAN16, FJ895384; TAN18, FJ895396; TAN19, FJ895402; TAN20,
FJ895401 and FJ895390; TAN21, FJ895392. Regions of the sequences that could
not be unambiguously aligned were removed from further analyses. For SIVcp-
zUG38, SIVcpzUG31, and SIVcpzTAN5, deduced Gag, Pol, Vif, and Env se-
quences were aligned with the corresponding protein sequences in HIV-1, P. t.
troglodytes SIVcpz (SIVcpzPtt), and SIVcpzPts reference strains (GenBank ac-
cession numbers for HIV-1 strains were K03455 for group M HXB2, AJ006022
for group N YBF30, L20587 for group O ANT70, and GU1115555 for group P
RB168; GenBank accession numbers for SIVcpzPtt strains were X52154 for
GAB1, AF115393 for CAM3, AJ271369 for CAM5, AY169968 for CAM13,
AF103818 for US, DQ373063 for MB66, DQ373064 for LB7, DQ373065 EK505,
and DQ373066 for MT145; and the GenBank accession number for SIV gorilla
[SIVgor] strain CP684 was FJ424871). Gag/Pol and Pol/Vif protein overlaps were
removed from the N and C termini of the deduced Pol protein sequences. In
addition, the concatenated Pol and Vif alignment was divided into two regions
around a previously reported recombination breakpoint between the SIVcpz-
CAM3/CAM5/US and HIV-1 group N lineages (8, 45). Appropriate evolutionary
models for phylogenetic analyses were selected using the ModelTest (33) and
ProtTest (1) programs. Phylogenetic trees were constructed using maximum
likelihood (12) and Bayesian (36) methods, the latter with a 25% burn-in and
using as a convergence criterion an average standard deviation of partition
frequencies of 0.01.
Nucleotide sequence accession numbers. New SIVcpzPts sequences have been
deposited in GenBank under accession numbers JN054704 to JN054707 and
JN091690 to JN091702; the new P. t. schweinfurthii mitochondrial D-loop se-
quences are available under accession numbers JN091703 and JN091704.
RESULTS
Demographics of study population. To examine whether the
chimpanzees of Gombe were the only apes in Tanzania with
endemic SIVcpz infection, we conducted a noninvasive survey
of savanna chimpanzees in the Ugalla region approximately
135 km to the south of Gombe (Fig. 1B). Fecal specimens were
collected between February 2009 and March 2010 at two lo-
cations: 375 samples were obtained in an 85-km2 area of the
Issa Valley, while an additional 6 samples were collected at a
single site near the Shangwa River approximately 20 km south-
west of the Issa Valley base camp (Fig. 1B). To estimate the
number of sampled individuals, fecal samples were subjected
to mitochondrial and microsatellite analyses. Of 381 samples,
44 (43 from the Issa Valley site and 1 from the Shangwa River
site) were not usable because they either were not of chimpan-
zee origin (n  2), represented fecal admixtures (n  23), or
were too degraded for further analysis (n 19). The remaining
337 fecal samples were genotyped at eight microsatellite loci,
which identified a total of 72 individuals, 67 in the Issa Valley
and 5 at the Shangwa River site (Table 1; see Table S1 in the
supplemental material). It should be noted that this represents
a minimum estimate, since up to four allelic mismatches were
permitted to exclude possible allelic dropout due to specimen
degradation.
Members of individual chimpanzee communities range to-
gether over a circumscribed geographic area, usually traveling
in small temporary parties. Since many of the Issa Valley chim-
panzees were sampled on more than one occasion (range, 1 to
13), their movement in space and time could be examined.
These analyses documented associations among 64 of the 67
individuals, indicating that they shared the same social network
as well as habitat. The remaining three, who were sampled only
once, lacked such association but were identified in the same
geographic area. It is thus likely that all 67 Issa Valley chim-
panzees, including 31 females, 27 males, and 9 individuals
whose sex could not be determined, comprised members of a
single community. In contrast, the four males and one female
sampled at the Shangwa River site did not share any co-nesting
associations with the Issa Valley chimpanzees and thus do not
seem to belong to the Issa Valley community (see Table S1 in
the supplemental material).
Chimpanzee population density and home range in Ugalla.
Chimpanzees build nightly sleeping nests, and together with
estimates of sighting distances, nest decay rates, the proportion
of nests reused, and the proportion of infants (who do not
build independent nests), the resulting counts can be used to
generate estimates of population density (17, 31). Previous
nest surveys using these methods within the Issa Valley study
area of 85 km2 yielded a density estimate of 0.14 individual/
km2, but surveys of nearby areas yielded estimates as low as
0.03/km2 (28). When the size of a community is known, an
estimate of home-range size can be obtained by the reciprocal
of the population density; e.g., at a density of 0.14 individual/
km2 in Issa Valley, a community of 67 (see above) would
occupy a minimum range of 478 km2, assuming no overlap in
nesting areas with neighboring communities. In reality, calcu-
lating home-range sizes from nest-based densities underesti-
mates the actual home range because (i) nesting areas may
overlap and (ii) individuals may make excursions during the
day and then return toward the center of their range to sleep.
High prevalence of SIVcpz infection in Ugalla. To determine
whether the chimpanzees of Ugalla were SIVcpz infected, we
tested all genotyped fecal samples for the presence of antibod-
ies using a highly sensitive and specific Western blot approach
(16). None of the five Shangwa River site samples were SIVcpz
positive (Table 1; see Table S1 in the supplemental material);
however, 96 fecal specimens from 21 Issa Valley chimpanzees
exhibited clear evidence of SIVcpz infection (Fig. 2). Impor-
tantly, 14 of these individuals were sampled on more than one
occasion, and except for two newly infected apes (see below),
all specimens were fecal antibody positive, consistent with the
fact that SIVcpz causes a persistent life-long infection. Thus,
the prevalence of SIVcpz infection in the Issa Valley commu-
nity was 31%, with 95% confidence limits ranging from 21% to
44%. Combining the individual test sensitivity (0.92) with the
number of repeat samples per chimpanzee (from 1 to 13)
increased the average overall sensitivity to 0.98, which raised
the prevalence estimate only marginally, to 32%. There was no
evidence of SIVcpz infection at the Shangwa River site; how-
ever, because only five chimpanzees were sampled there only
once, the prevalence at the Shangwa River site may not really
be different from that for Issa Valley, especially since the five
chimpanzees likely represent only a subset of a larger commu-
nity. Thus, the possibility of SIVcpz infection in the Sangwa
River area cannot be excluded.
Continuing spread of SIVcpz in Ugalla. Repeat sampling of
a subset of individuals also provided an opportunity to look for
incident infections. This analysis identified two chimpanzees,
one male (Ch-03) and one female (Ch-64), who became newly
infected over the 14-month observation period (Table 2).
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viral RNAfD18s536 D4s243 D10s676 D9s922 D2s1326 D2s1333 D4s1627 D9s905
Ch-01 F 1 6/12/09 GM10 135/139 194/198 179/183 282/286 259/267 NAg NA 293/293 Pos
Ch-02 M 1 12/19/09 GM10 139/159 218/230 183/187 270/282 251/263 321/325 221/221 281/293 Neg
Ch-03 M 12 11/2/09–3/5/10 GM10 139/175 218/230 179/183 286/286 251/251 317/321 221/233 285/293 Pos* pol, gp41, gp41/nef
Ch-04 F 7 7/23/09–11/6/09 GM10 159/175 218/230 175/183 286/298 251/263 317/325 221/233 285/293 Neg
Ch-05 F 8 6/27/09–11/20/09 GM10 159/159 198/218 183/183 290/298 247/251 317/321 221/221 285/285 Neg
Ch-06 F 6 3/06/09–11/20/09 GM10 159/175 202/218 179/183 270/286 231/263 325/337 221/221 293/293 Pos
Ch-07 Unk 1 NA GM10 159/159 198/198 183/183 NA 239/251 NA NA NA Neg
Ch-08 M 7 2/7/09–3/1/10 GM7 135/175 202/230 183/195 270/302 255/263 321/337 221/221 293/293 Neg
Ch-09 F 5 6/26/09–3/1/10 GM7 135/175 194/230 183/195 286/302 243/255 321/325 221/229 293/293 Neg
Ch-10 Unk 1 12/7/09 GM7 139/139 198/234 179/183 286/290 231/231 NA 221/225 281/293 Pos
Ch-11 Unk 2 11/06/09–11/13/09 GM7 139/139 202/230 179/183 270/286 263/263 321/321 221/225 269/293 Neg
Ch-12 M 5 10/11/09–11/20/09 GM7 139/159 194/198 179/183 270/302 251/263 321/337 221/233 289/293 Neg
Ch-13 F 8 7/02/09–2/15/10 GM7 139/159 194/202 175/187 302/302 255/263 321/321 221/233 285/293 Neg
Ch-14 F 7 10/11/09–12/15/09 GM7 139/159 198/234 179/183 290/302 263/263 321/337 221/221 293/293 Neg
Ch-15 M 3 8/14/09–10/19/09 GM7 139/159 202/230 179/183 282/290 231/263 321/337 221/221 281/293 Pos pol, gp41, gp41/nef
Ch-16 F 1 12/15/09 GM7 139/159 198/230 175/175 290/298 251/263 NA 209/233 285/293 Neg
Ch-17 F 8 6/12/09–12/15/09 GM7 139/159 230/230 175/183 286/290 231/251 321/321 221/221 269/293 Pos gp41, gp41/nef
Ch-18 F 7 6/12/09–12/30/09 GM7 139/171 230/234 175/179 286/290 263/263 321/325 221/225 285/293 Pos pFL
Ch-19 M 3 6/12/09–11/14/09 GM7 139/175 202/230 183/183 286/290 251/255 317/321 221/233 281/293 Neg
Ch-20 F 10 7/2/09–2/15/10 GM7 151/159 194/218 175/179 282/290 251/255 317/317 233/233 285/293 Neg
Ch-21 M 5 7/2/09–2/22/10 GM7 159/159 194/230 175/183 282/298 251/255 317/317 221/233 281/285 Neg
Ch-22 M 9 7/2/09–3/5/10 GM7 159/175 202/202 175/183 298/302 251/263 317/321 221/221 285/293 Neg
Ch-23 M 2 11/2/09–2/14/10 GM7 159/175 202/218 183/187 286/302 251/263 321/321 221/221 293/293 Neg
Ch-24 Unk 1 2/11/10 GM7 159/159 202/202 NA 262/262 NA NA 221/221 NA Pos
Ch-25 M 6 8/2/09–11/14/09 GM8 159/159 194/230 179/183 270/270 251/255 321/325 221/221 293/293 Pos pol, gp41, gp41/nef
Ch-26 M 9 7/2/09–11/1/09 GM8 159/159 202/234 183/191 298/302 251/255 329/337 221/221 293/293 Pos pol, gp41, gp41/nef
Ch-27 Unk 1 11/13/09 GM8 139/139 202/234 179/179 286/286 251/267 NA 221/233 281/285 Neg
Ch-28 F 4 8/1/09–8/14/09 MH32 135/139 194/198 179/183 282/286 259/267 317/321 233/233 293/293 Neg
Ch-29 M 5 7/27/09–11/6/09 MH32 139/159 194/230 179/183 282/286 247/255 321/321 221/221 293/293 Neg
Ch-30 M 1 12/15/09 MH32 139/139 198/230 175/179 282/290 251/263 321/321 209/221 281/293 Neg
Ch-31 F 1 11/4/09 MH32 135/139 NA 183/183 NA 255/255 NA 221/221 293/293 Pos
Ch-32 M 9 7/27/09–12/15/09 MH32 139/139 230/230 179/187 282/286 247/251 321/325 221/221 281/293 Pos
Ch-33 F 2 10/31/09–12/30/09 MH32 139/159 194/234 175/195 286/298 259/263 321/325 221/225 285/293 Neg
Ch-34 M 5 6/12/09–12/15/09 MH32 139/159 194/198 183/195 270/270 251/255 325/337 221/221 293/293 Neg
Ch-35 M 1 10/1/09 MH32 139/159 198/202 183/183 290/290 231/231 321/337 221/221 285/293 Neg
Ch-36 F 12 8/2/09–2/12/10 MH32 139/159 198/202 175/195 270/290 251/255 337/337 221/221 293/293 Neg
Ch-37 F 9 8/2/09–2/1/10 MH32 139/159 198/218 175/179 286/306 243/263 321/321 221/225 285/293 Neg
Ch-38 F 6 3/19/09–10/11/09 MH32 139/159 198/230 175/175 290/298 251/263 301/321 209/233 285/293 Neg
Ch-39 M 1 10/31/09 MH32 139/159 198/234 179/183 290/302 263/263 321/337 221/221 293/293 Pos
Ch-40 M 9 8/2/09–12/30/09 MH32 139/159 202/230 179/179 286/306 255/255 325/337 221/221 281/293 Pos gp41, gp41/nef
Ch-41 M 5 7/27/09–11/14/09 MH32 139/159 202/234 179/179 282/286 251/255 321/325 221/221 281/293 Pos
Ch-42 M 4 6/12/09–12/30/09 MH32 139/159 218/234 175/179 286/286 259/263 321/321 221/225 285/293 Neg
Ch-43 F 1 8/14/09 MH32 139/159 230/230 175/183 286/290 231/251 321/321 221/221 293/293 Pos
Ch-44 M 2 6/12/09 MH32 139/159 230/234 175/183 286/298 231/259 321/321 221/221 281/293 Pos pol, gp41, gp41/nef
Ch-45 F 3 6/12/09–11/6/09 MH32 139/175 194/230 179/179 270/286 263/263 NA 221/221 293/293 Neg
Ch-46 M 1 10/4/09 MH32 159/175 194/202 175/183 270/290 255/259 317/321 221/221 293/293 Neg
Ch-47 F 3 6/12/09–10/12/09 MH32 159/159 194/202 179/183 286/286 255/263 321/325 221/221 285/293 Neg
Ch-48 F 3 10/11/09–10/12/09 MH32 159/171 194/202 175/179 270/286 251/263 325/325 221/221 281/285 Pos
Ch-49 F 7 6/12/09–11/6/09 MH32 159/175 194/194 179/195 286/286 251/263 321/325 225/233 285/285 Neg
Ch-50 Unk 1 12/15/09 MH32 159/175 218/230 175/183 286/298 251/263 317/325 221/233 285/293 Neg
Ch-51 F 4 7/27/09–11/5/09 MH32 171/175 194/202 175/175 286/290 231/259 317/317 221/221 293/293 Neg
Ch-52 F 1 11/6/09 MH32 139/159 198/198 175/199 290/290 NA NA NA 285/293 Neg
Ch-53 F 9 6/12/09–11/13/09 MH37 159/171 230/230 183/183 290/298 251/255 309/337 221/221 269/269 Neg
Ch-54 M 6 10/12/09–12/15/09 UG135 151/159 198/202 175/183 270/286 231/255 321/325 221/221 293/293 Neg
Ch-55 F 1 12/16/09 UG59 131/159 230/230 179/179 NA 251/255 NA 221/221 293/293 Neg
Ch-56 F 3 11/2/09–2/22/10 UG59 139/159 194/230 175/195 286/298 259/263 317/337 217/221 281/293 Neg
Ch-57 M 13 3/7/09–2/22/10 UG59 139/159 198/202 183/183 290/290 231/263 321/337 221/221 285/293 Neg
Ch-58 F 7 6/14/09–2/23/10 UG59 139/159 202/202 175/183 286/290 231/263 337/337 221/221 269/293 Pos FL
Ch-59 F 12 8/14/09–2/12/10 UG59 139/159 202/230 179/179 286/286 255/263 317/321 221/221 285/293 Neg
Ch-60 Unk 1 10/31/09 UG59 139/159 202/230 175/183 270/290 231/231 NA 221/221 269/269 Neg
Ch-61 Unk 1 11/2/09 UG59 139/159 230/230 175/183 270/286 251/263 NA 221/233 269/285 Pos
Ch-62 M 2 7/30/09–8/9/09 UG59 139/179 198/198 183/183 270/290 263/263 321/325 221/233 285/293 Neg
Ch-63 F 13 3/7/09–2/15/10 UG59 159/175 194/230 179/179 270/286 255/263 321/337 221/221 285/293 Neg
Ch-64 F 10 3/7/09–2/22/10 UG59 139/159 230/234 175/179 270/286 251/263 321/325 221/221 269/281 Pos* gp41, gp41/nef
Ch-65 M 1 10/26/09 UG59 159/159 194/230 175/183 282/298 251/255 317/317 221/233 281/285 Neg
Ch-66 M 12 2/24/09–2/23/10 UG59 159/175 198/202 183/183 282/290 259/263 321/325 229/233 269/293 Neg
Ch-67 F 5 3/9/09–2/22/10 UG59 175/179 194/198 183/191 270/290 263/263 321/321 233/233 269/293 Neg
a Non-boldface type, uninfected; boldface type, infected.
b F, female; M, male; Unk, unknown.
c MH and GM haplotypes have previously been reported (15, 20, 37); UG haplotypes have been deposited in GenBank (accession numbers JN091703 and JN091704).
d Consensus genotypes are shown.
e WB, Western blot; Pos, positive; Neg, negative; asterisks, the two individuals which became newly infected during our survey.
f FL, full-length genome; pFL, partial full-length genome.
g NA, not available.
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Ch-03 was negative for SIVcpz infection on two occasions in
November 2009; however, a sample taken 3 months later was
both antibody and viral RNA positive. Samples from two sub-
sequent time points were also antibody and/or viral RNA pos-
itive. Similarly, Ch-64 was SIVcpz negative in March 2009, but
a sample taken 3 months later was antibody and viral RNA
positive. Samples obtained at six subsequent time points were
also antibody positive (Tables 2; see Table S1 in the supple-
mental material). Since each of these two individuals had at
least two early negative samples, the chance of misdiagnosis
due to false-negative testing is less than 1%. Interestingly,
Ch-03 and Ch-64 were infected with nearly identical viruses
(see below). This suggests either that one transmitted SIVcpz
to the other or that both became infected from a common
source. Irrespective of the circumstances, the finding of two
incident infections within a 14-month time frame indicates that
SIVcpz continues to spread in the Ugalla area.
Phylogeography of Ugalla SIVcpz. To characterize the newly
identified SIVcpz infections, we used consensus primers to
amplify subgenomic pol and gp41/nef viral fragments (15, 16,
FIG. 2. Evidence of SIVcpz infection in Ugalla. Chimpanzee fecal samples were tested for SIVcpz-specific antibodies using an enhanced
chemiluminescent Western blot approach and HIV-1 antigen-containing strips. Samples are numbered, with the corresponding individual denoted
on the bottom (also see Table S1 in the supplemental material). Molecular weights of HIV-1 specific proteins are indicated. The banding patterns
of plasma from an HIV-1-infected patient (positive [pos] at a 1:10,000 dilution) and an uninfected human control (neg) are shown.
















viral RNAD18s536 D4s243 D10s676 D9s922 D2s1326 D2s1333 D4s1627 D9s905
Ch-03 M 253 2-Nov-09 GM10 139/175 218/230 179/183 286/286 251/251 317/321 221/233 285/293 Neg
284 2-Nov-09 GM10 139/175 218/230 179/183 286/286 251/251 221/233 285/— Neg
211 4-Nov-09 GM10 139/175 218/230 179/— 286/286 251/251 221/233 285/293 Neg Neg
M 305 15-Feb-10 GM10 139/175 218/230 179/183 286/286 251/251 317/321 221/233 285/293 Pos gp41
323 15-Feb-10 GM10 139/175 218/230 179/183 286/286 251/251 221/233 285/293 Pos
298 22-Feb-10 GM10 139/175 218/230 179/183 286/286 251/251 317/321 221/233 285/293 Pos pol
300 22-Feb-10 GM10 139/175 218/230 179/183 286/286 251/251 317/321 221/233 285/293 Pos pol, gp41, gp41/nef
306 22-Feb-10 GM10 139/175 218/230 179/183 286/286 251/251 317/321 221/233 285/293 Pos pol, gp41
336 22-Feb-10 GM10 139/175 218/230 179/183 286/286 251/251 317/321 221/233 285/293 Pos
341 22-Feb-10 GM10 139/175 218/230 179/183 286/286 251/251 221/233 285/293 Pos
334 5-Mar-10 GM10 139/— 218/230 179/— 286/286 251/251 221/233 285/293 Pos
307 NAf GM10 139/175 218/230 179/183 286/286 251/251 221/233 285/293 Pos
Ch-64 F 11 7-Mar-09 UG59 —/159 230/234 175/— 270/286 251/263 321/325 221/221 269/281 Neg
F 17 7-Mar-09 UG59 —/159 230/234 175/— 270/286 251/263 221/221 269/281 Neg Neg
F 59 30-Jul-09 UG59 —/159 230/234 175/— 270/286 251/263 321/325 221/221 269/281 Pos gp41, gp41/nef
286 2-Nov-09 UG59 —/159 230/234 175/— 270/286 251/263 221/221 269/281 Pos
206 4-Nov-09 UG59 —/159 230/234 175/— 270/286 251/263 321/325 221/221 269/281 Pos
177 20-Dec-09 UG59 —/159 230/234 175/— —/286 251/263 221/221 269/281 Pos
167 29-Dec-09 UG59 139/159 230/234 175/179 270/286 251/263 221/221 269/281 Pos
317 15-Feb-10 UG59 —/159 230/234 175/— 270/286 251/263 321/325 221/221 269/281 Pos
308 22-Feb-10 UG59 —/159 230/234 175/— 270/286 251/263 221/221 269/281 Pos
309 22-Feb-10 UG59 —/159 230/234 175/— 270/286 251/263 321/325 221/221 269/281 Pos
a Non-boldface type, uninfected; boldface type, infected.
b F, female; M, male.
c MH and GM haplotypes have previously been reported (15, 20, 37); UG haplotypes have been deposited in GenBank (accession numbers JN091703 and JN091704).
d Microsatellite loci are indicated. —, alleles that did not amplify; empty cells, loci that failed to amplify.
e WB, Western blot; Pos, positive; Neg, negative.
f NA, not available.
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37, 41). Using all available samples as well as up to eight
different RT-PCR attempts, we were able to detect SIVcpz
sequences in 10 of the 21 infected individuals. Amplified re-
gions included 231 to 669 bp of pol, 239 to 278 bp of gp41, and
545 to 791 bp of gp41/nef (Table 1; see Table S1 in the sup-
plemental material). Our failure to amplify viral RNA from the
remaining 11 infected individuals was most likely caused by
viral RNA degradation due to extended sample storage at
ambient temperatures.
To determine the evolutionary relationships of the Ugalla
viruses to each other and to previously characterized SIVcpz
strains, we constructed phylogenetic trees from subgenomic
gp41/nef and pol sequences (Fig. 3). These analyses showed
that all 10 Ugalla viruses clustered together, forming a mono-
phyletic lineage within the clade of SIVcpz from P. t. schwein-
furthii apes (SIVcpzPts). The closest relatives of the Ugalla
viruses were SIVcpz strains from Gombe National Park (Fig. 1B).
As shown in Fig. 3, all Ugalla viruses fell within the radiation of
Gombe SIVcpz, forming a sister clade to the main Gombe group.
Interestingly, one Gombe virus (SIVcpzTAN13) previously iden-
tified in a young female who was first observed in Gombe in
1993 and is believed to be the daughter of an immigrant (37)
formed an outgroup to both the Ugalla and the main Gombe
clades. This divergent lineage, which was observed in both pol
and gp41/nef trees, may thus represent an independent intro-
duction of SIVcpz into Gombe, suggesting that some (or all) of
the Ugalla and Gombe lineages originated in chimpanzee com-
munities that have not yet been identified or may no longer
exist. Alternatively, SIVcpz may have been introduced into
Gombe a long time ago, and the Ugalla lineage could have
originated there. Although current data are not sufficient to
trace the origin of either the Gombe or Ugalla viruses, they
indicate that these now separated communities must have been
connected, either directly or indirectly, at some point in the
past.
Analysis of Ugalla SIVcpz genomes. To examine the evolu-
tionary relationship of the Ugalla viruses over the entire length
of their genomes, we amplified one full-length (UG38) and one
partial (UG31) SIVcpz strain from fecal samples with high
RNA loads (Fig. 4A). In addition, we amplified the genome of
SIVcpzTAN5, a Gombe virus representing a lineage not pre-
viously characterized. Fecal RNA was extracted and subjected
to RT-PCR analysis using consensus as well as strain-specific
primers. For UG38 and TAN5, this approach yielded 10 to 11
partially overlapping fragments, which in each case spanned
the entire proviral genome (Fig. 4A). Amplification of UG31
was more difficult. Despite repeated RT-PCR attempts, only
seven fragments spanning parts of gag, pol, and the accessory
gene region could be amplified (Fig. 4A). All amplicons were
sequenced directly and concatenated to generate fecal consen-
sus sequences. As expected, these contained a limited number
of ambiguous sites, which were resolved as previously de-
scribed (48).
The concatenated sequences of UG38, UG31, and TAN5
were 9,283 bp, 5,783 bp, and 9,893 bp in length, respectively,
and all viral genes within these sequences contained intact
open reading frames. The new sequences allowed us to exam-
ine previously identified SIVcpzPts signatures (40). Both
Ugalla viruses and TAN5 contained insertions of 4 to 5 amino
















































































FIG. 3. Phylogeny of SIVcpz from Ugalla. Maximum likelihood trees (12) were constructed from partial pol (HXB2 coordinates 4107 to 4775)
(A) and gp41/nef (HXB2 coordinates 8358 to 9054) (B) sequences. Newly characterized SIVcpz strains from Ugalla are highlighted in red; asterisks
denote two incident infections. Previously characterized viruses from Gombe and the Democratic Republic of the Congo are shown in blue and
black, respectively. Numbers indicate posterior probability values for the clustering of the clade immediately to the right (only values above 0.95
are shown). The scale bars represent 0.05 (A) and 0.1 (B) substitutions per site.
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nus of Vif. Moreover, their Vpr proteins were 89 to 90 amino
acids in length and, thus, about 10 residues shorter than the
Vpr proteins typically found in SIVcpz from central chimpan-
zees (SIVcpzPtt). Finally, UG38, UG31, and TAN5 contained
a 5-amino-acid deletion in the C terminus of Nef and an 8- to
11-amino acid insertion in the ectodomain of gp41 compared
to SIVcpzPtt strains. Thus, the newly sequenced Ugalla viruses
as well as TAN5 contained signatures typical of SIVcpzPts
strains (40).
To determine the relationships of UG38, UG31, and TAN5
to other SIVcpz strains, we performed distance and phyloge-
netic tree analyses. Figure 4B illustrates the distances between
UG38 and each of UG31, TAN5, and ANT (the first described
SIVcpzPts strain) across the length of their genomes. As ex-
pected, UG38 and UG31 were most similar in all genomic
regions, while TAN5 and, in particular, ANT were more dis-
tant. We also constructed trees from Gag (420 aa), N-terminal
Pol (630 aa), C-terminal Pol/Vif (453 aa), and Env (729 aa)
protein sequences (Fig. 5). These analyses confirmed the rela-
tionships derived from the partial pol and gp41/nef sequences
and revealed no evidence for recombination between the ma-
jor SIVcpzPts lineages. Thus, the available Ugalla and Gombe
viruses exhibited phylogeographic clustering, forming two sis-
ter clades within the SIVcpzPts radiation.
DISCUSSION
Studies of SIVcpz in Tanzania began in 2000, when infection
was first identified in Gombe National Park (42). This discov-
ery prompted surveys of other chimpanzee communities in
East Africa, including the M group in Mahale (Fig. 1B), none
of which uncovered additional infections (44). In contrast, sur-
veys of wild apes in the Democratic Republic of the Congo
revealed SIVcpz infection at multiple different field sites (19,
43). Thus, the presence of SIVcpz in Gombe seemed to rep-
resent an isolated case, possibly the remnant of a previously
more widespread infection that had largely gone extinct. To
test this hypothesis, we conducted a survey in the Masito-
Ugalla region of the Greater Mahale Ecosystem, which com-
prises one of the largest remaining chimpanzee habitats in
western Tanzania. There were two reasons for selecting this
particular area. First, we wished to test populations that were
less geographically confined than those in Gombe and Mahale
Mountains National Parks (22, 25, 26, 32). Second, we were
intrigued by the ecology of savanna chimpanzees, which pro-
vided an opportunity to study a low-density ape population.
Testing fecal samples from just two collection sites yielded a
number of unexpected results. First, we found that the 67 Issa
Valley chimpanzees all shared the same home range, indicat-
ing a community size much larger than that of other known
savanna chimpanzees (4, 34, 46). Second, we discovered
SIVcpz infection among these apes, indicating that there was,
in fact, a second area of SIVcpz endemicity in Tanzania. Third,
we found that 21 of 67 savanna chimpanzees were infected,
indicating that even low-density ape populations can harbor
SIVcpz at high prevalence rates. Finally, we documented two
incident SIVcpz infections in Issa Valley, indicating ongoing
virus spread among chimpanzees in this area.
Nearly one-third of chimpanzees sampled within an 85-km2
area of the Issa Valley harbored SIVcpz. This rate of infection
is at the upper end of prevalence rates previously determined
for wild-living populations (16, 19, 37, 41, 49), with only the
Kalande community in Gombe consistently exhibiting a larger
proportion of infected individuals (37, 41). Previous surveys
estimated the population density of chimpanzees in the Ugalla
region to be 0.08 individual/km2, with a slightly higher density
in the Issa Valley (0.14 individual/km2) (26). Thus, these sa-
vanna chimpanzees live at 20- to 50-fold lower population
densities than the forest chimpanzees in Gombe and Mahale
(25). For SIVcpz to be able to spread and persist in a popu-
lation, the basic reproductive number, R0, must be greater than
1. For sexually transmitted diseases, R0 is the product of the
transmission probability per partnership (), the rate of part-
ner change (c), and the duration of infectiousness (D), i.e.,










































































FIG. 4. Molecular characterization of full-length SIVcpz proviruses.
(A) Individual RT-PCR amplicons (shaded boxes) of SIVcpzUG38,
SIVcpzUG31, and SIVcpzTAN5 are shown in relation to the SIVcpz
genome (top). All fragments are drawn to scale, with nucleotide se-
quences numbered starting at the beginning of the R region in the 5 LTR
(see scale bar). (B) Distance plots illustrating the extent of nucleotide
sequence divergence between SIVcpzUG38 and SIVcpzUG31 (red),
SIVcpzTAN5 (blue), and SIVcpzANT (green). Differences were calcu-
lated for windows of 300 bp moved in steps of 20 bp along the alignment;
values are plotted at the midpoint of the window. Arrows indicate the start
of the gag, pol, vif, vpr, env, and nef reading frames.
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R0  cD (for a review, see reference 2). Although population
density does not directly factor into this equation, it might be
expected to influence the number of sexual contacts and part-
ner turnover. In fact, a recent study in beetles demonstrated
that the spread of a sexually transmitted disease (a parasitic
mite) was more dependent on the population density of in-
fected individuals than their proportion within the population
(38). Importantly, our data indicate that the low population
density in Ugalla has not impeded the spread of SIVcpz among
these savanna chimpanzees.
The finding of 67 individuals within the Issa Valley study
area, 64 of whom were interconnected by joint nesting episodes
or diurnal associations, was surprising. Other known savanna
chimpanzee communities are either much smaller (28 to 35
individuals) (4, 34) or from sites with appreciably greater pop-
ulation densities (0.2 to 0.7/km2) (14, 46). The significance of
such a large community (a minimum of 67 individuals) living at
such a low density (less than 0.14 individual/km2) is that the
implied home range is enormous, i.e., greater than 478 km2,
which is nearly twice the size of the largest similarly estimated
home range published to date (4). Such a vast home range
would be expected to have major consequences for within- and
between-community social behaviors, including those affecting



























































































































































FIG. 5. Evolutionary relationships of Ugalla SIVcpz derived from full-length genome sequences. Trees were inferred by the Bayesian method
(36) from amino acid sequence alignments of the major proteins, Gag (420 aa), N-terminal Pol (630 aa), C-terminal Pol/Vif (453 aa), and Env (729
aa); the Pol protein was separated into two fragments at a point where a recombination breakpoint was previously identified in HIV-1 group N
(8, 45). SIVcpz strains from Ugalla and Gombe are highlighted in red and blue, respectively; HIV-1 group M to P, SIVgor, SIVcpzPtt, and
SIVcpzPts reference sequences are shown in black. Numbers on internal branches indicate posterior probabilities (only values of 0.95 or greater
are shown). Branches with posterior probability values of less than 0.5 were collapsed. The scale bars represent 0.05 amino acid replacement per
site.
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prevalence implies that the number of contacts between dif-
ferent community members is similar to that of forest chim-
panzees. Additional research will be necessary to resolve this
seeming paradox.
Molecular characterization of the newly identified viruses
revealed a close genetic relationship of Ugalla and Gombe
viruses (Fig. 3 and 5). Viruses from each community formed
well-defined lineages in phylogenetic trees, with one Gombe
strain outflanking both the main Gombe and Ugalla clades
(Fig. 3). The SIVcpz strains from Gombe and Ugalla share a
recent common ancestor, but the historical links between these
communities are unclear. Since the 1940s, human settlements
and deforestation have significantly reduced chimpanzee hab-
itat between Gombe and Ugalla (35), and the original distri-
bution of chimpanzees in this area is not known. The Malaga-
rasi River forms the northern border of the Ugalla region and
could represent a biogeographic barrier. Only two isolated
chimpanzee communities occur between Gombe and this river,
i.e., Kwitanga 15 km east of Gombe and Lilanshimba on the
north side of the Malagarasi (Fig. 1B) (29, 35). Our finding of
related viruses in Gombe and Ugalla thus suggests either that
chimpanzees were previously able to cross the Malagarasi
River or that SIVcpz was introduced into Gombe and Ugalla
from the west shore of Lake Tanganyika by two separate
routes, i.e., from the north through Burundi to Gombe and
from the south through Zambia to the Mahale/Masito/Ugalla
ecosystem. Among these, the former explanation seems more
likely.
Land surveys between Mahale and Ugalla have provided
ample evidence for the presence of chimpanzees, suggesting
that large parts of this vast area are suitable chimpanzee hab-
itats (Fig. 1B). Although human encroachment, including the
Mishamo Refugee Settlement (measuring 55 km by 23 km)
between Mahale and Ugalla, may hinder chimpanzee move-
ment, no major geographical barriers exist that would prevent
virus spread within the Mahale and Ugalla region. We have
previously failed to detect SIVcpz in Mahale Mountains Na-
tional Park, but our study was limited to only 20 individuals
from one particular community (44). The Greater Mahale
Ecosystem—which includes Ugalla—is believed to provide
habitat for approximately 2,600 chimpanzees (26). It will thus
be critical to determine to what extent SIVcpz has penetrated
this population. In this context, the pathogenic potential of
SIVcpz has to be considered. While chimpanzee density in
Ugalla does not seem to have changed much since the 1960s
(26), data from the Kalande community in Gombe would sug-
gest that the impact of SIVcpz on chimpanzee population
growth has a considerable lag time (37). It is thus possible that
any detrimental effect of SIVcpz on these savanna chimpan-
zees may have not yet manifested itself.
In summary, we report here that SIVcpz infection in Tan-
zania is more widespread than previously appreciated. We also
provide evidence that a large number of some of the most
endangered, yet largely unstudied, ape populations in Tanza-
nia are at risk of SIVcpz infection. Given the value of these
communities to different disciplines, it will be critical to deter-
mine whether and to what extent other savanna chimpanzees
across western Tanzania harbor SIVcpz, in order to be able to
gauge what impact this infection might have on their long-term
survival.
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